Journal Title：International Immunopharmacology

International Immunopharmacology is the primary vehicle for the publication of original research papers pertinent to the overlapping areas of immunology, pharmacology, cytokine biology, immunotherapy, immunopathology and immunotoxicology. Review articles that encompass these subjects are also welcome.

The subject material appropriate for submission includes:

? Clinical studies employing immunotherapy of any type including the use of: bacterial and chemical agents; thymic hormones, interferon, lymphokines, etc., in transplantation and diseases such as cancer, immunodeficiency, chronic infection and allergic, inflammatory or autoimmune disorders.

? Studies on the mechanisms of action of these agents for specific parameters of immune competence as well as the overall clinical state.

? Pre-clinical animal studies and in vitro studies on mechanisms of action with immunopotentiators, immunomodulators, immunoadjuvants and other pharmacological agents active on cells participating in immune or allergic responses.

? Pharmacological compounds, microbial products and toxicological agents that affect the lymphoid system, and their mechanisms of action.

? Agents that activate genes or modify transcription and translation within the immune response.

? Substances activated, generated, or released through immunologic or related pathways that are pharmacologically active.

? Production, function and regulation of cytokines and their receptors.

? Classical pharmacological studies on the effects of chemokines and bioactive factors released during immunological reactions.

《國(guó)際免疫藥理學(xué)》是發(fā)表與免疫學(xué)、藥理學(xué)、細(xì)胞因子生物學(xué)、免疫療法、免疫病理學(xué)和免疫毒理學(xué)重疊領(lǐng)域相關(guān)的原創(chuàng)研究論文的主要載體。也歡迎涵蓋這些主題的評(píng)論文章。

適合提交的主題材料包括：

? 采用任何類型的免疫療法的臨床研究，包括使用：細(xì)菌和化學(xué)藥劑；胸腺激素、干擾素、淋巴因子等，在移植和癌癥、免疫缺陷、慢性感染和過(guò)敏、炎癥或自身免疫性疾病等疾病中的作用。

? 研究這些藥物對(duì)免疫能力特定參數(shù)以及整體臨床狀態(tài)的作用機(jī)制。

? 臨床前動(dòng)物研究和體外研究免疫增強(qiáng)劑、免疫調(diào)節(jié)劑、免疫佐劑和其他對(duì)參與免疫或過(guò)敏反應(yīng)的細(xì)胞有活性的藥劑的作用機(jī)制。

? 影響淋巴系統(tǒng)的藥理化合物、微生物產(chǎn)品和毒理劑及其作用機(jī)制。

? 激活基因或修改免疫反應(yīng)內(nèi)轉(zhuǎn)錄和翻譯的藥劑。

? 通過(guò)免疫或相關(guān)途徑激活、生成或釋放的具有藥理活性的物質(zhì)。

? 細(xì)胞因子及其受體。

? 關(guān)于免疫反應(yīng)過(guò)程中釋放的趨化因子和生物活性因子作用的經(jīng)典藥理學(xué)研究。

International Immunopharmacology創(chuàng)刊于2001年，由Elsevier出版商出版，收稿方向涵蓋醫(yī)學(xué) - 免疫學(xué)全領(lǐng)域，此刊是該細(xì)分領(lǐng)域中屬于非常不錯(cuò)的SCI期刊，在行業(yè)細(xì)分領(lǐng)域中學(xué)術(shù)影響力較大，專業(yè)度認(rèn)可很高，所以對(duì)原創(chuàng)文章要求創(chuàng)新性較高，如果您的文章質(zhì)量很高，可以嘗試。平均審稿速度 約2.7個(gè)月 約7.5周，影響因子指數(shù)4.8，該期刊近期沒(méi)有被列入國(guó)際期刊預(yù)警名單，廣大學(xué)者值得一試。